BSX - Company ID 0000885725
The table below shows BOSTON SCIENTIFIC CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B |
| Cost of revenue | $6.22B | $5.26B | $4.34B | $3.96B | $3.71B | $3.46B |
| Gross profit | $13.85B | $11.49B | $9.90B | $8.73B | $8.18B | $6.45B |
| R&D | - | - | - | - | - | - |
| SG&A |
BOSTON SCIENTIFIC CORP reported annual revenue of $20.07B for fiscal year 2025. That is up 19.9% from $16.75B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.08B (FY 2016) to $20.07B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $6.89B |
| $5.98B |
| $5.19B |
| $4.52B |
| $4.36B |
| $3.79B |
| Operating income | $3.61B | $2.60B | $2.34B | $1.65B | $1.20B | -$80.00M |
| Income tax | $493.00M | $436.00M | $393.00M | $443.00M | $36.00M | $2.00M |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | -$0.08 |